Director/PDMR Shareholding

Optima Health PLC
16 October 2024
 

16 October 2024

 

 

Optima Health plc

("Optima Health" or the "Company")

Director / PDMR Shareholdings

 

Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces the following transactions in the Company's Ordinary Shares were undertaken by Persons Discharging Managerial Responsibilities.

The Company was notified on 14 October 2024, that Joanne Newey, a PDMR of the Company, (Group Business Development & Propositions Director) purchased 12,500 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 159 pence per share.

Following this, Joanne Newey holds an interest of 70,034 Ordinary Shares, representing approximately 0.08% of the current issued share capital. 

The Company was notified on 15 October 2024, that Heidi Giles, an Executive Director of the Company, (Chief Financial Officer) purchased 12,194 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 163.95 pence per share.

Following this, Heidi Giles holds an interest of 69,728 Ordinary Shares, representing approximately 0.08% of the current issued share capital. 

Contacts:

Optima Health

 

Jonathan Thomas, CEO

Heidi Giles, CFO

+44(0)3300085113

media@OptimaHealth.co.uk

 

 

Nominated Adviser and Corporate Broker

 

Panmure Liberum Limited

+44 (0)20 3100 2000

Emma Earl / Will Goode / Mark Rogers / Rupert Dearden

 

 

 

UK Financial PR Adviser

ICR Consilium

Mary-Jane Elliott / Angela Gray / Chris Welsh

optimahealth@icrinc.com

 

About Optima Health

 

Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Joanne Newey

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Business Development & Propositions Director (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Optima Health plc

b)

 

LEI

 

 

213800TOPWJSRCW4ON08

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each



Identification code

GB00BRSCY602



b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)







Purchase Price

Volume




159 pence

12,500







d)

 

Aggregated information




- Aggregated volume

12,500 shares


159 pence

- Price




e)

 

Date of the transaction

 

 

14 October 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Heidi Giles

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Optima Health plc

b)

 

LEI

 

 

213800TOPWJSRCW4ON08

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each



Identification code

GB00BRSCY602



b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)







Purchase Price

Volume




163.95

12,194







d)

 

Aggregated information




- Aggregated volume

12,194 shares


 

163.95 pence

- Price




e)

 

Date of the transaction

 

 

15 October 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings